Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Executive Vice President* of $CB Sells 10,580 Shares

Automated

TIMOTHY ALAN BOROUGHS, the Executive Vice President* of $CB, sold 10,580 shares of the company on 11-24-2025 for an estimated $3,133,478. We received data on the trade from a recent SEC filing. This was a sale of approximately 45.5% of their shares of this class of stock. Following this trade, they now own 12,660 shares of this class of $CB stock.

$CB Insider Trading Activity

CB Insider Trades

$CB insiders have traded $CB stock on the open market 12 times in the past 6 months. Of those trades, 2 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:

  • JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 4 sales selling 45,586 shares for an estimated $13,112,584.
  • JOHN W KEOGH (President & COO) has made 1 purchase buying 9,809 shares for an estimated $2,874,135 and 1 sale selling 9,793 shares for an estimated $2,869,447.
  • TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 2 sales selling 11,430 shares for an estimated $3,384,390.
  • JOSEPH F WAYLAND (Executive Vice President and*) has made 0 purchases and 2 sales selling 11,091 shares for an estimated $3,274,291.
  • MICHAEL G ATIEH sold 538 shares for an estimated $154,707
  • MICHAEL CORBAT purchased 425 shares for an estimated $114,665

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CB Hedge Fund Activity

We have seen 895 institutional investors add shares of $CB stock to their portfolio, and 942 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CB Congressional Stock Trading

Members of Congress have traded $CB stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CB Analyst Ratings

Wall Street analysts have issued reports on $CB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Keefe, Bruyette & Woods issued a "Outperform" rating on 10/23/2025
  • JMP Securities issued a "Market Outperform" rating on 10/22/2025
  • Evercore ISI Group issued a "Outperform" rating on 10/01/2025

To track analyst ratings and price targets for $CB, check out Quiver Quantitative's $CB forecast page.

$CB Price Targets

Multiple analysts have issued price targets for $CB recently. We have seen 12 analysts offer price targets for $CB in the last 6 months, with a median target of $312.5.

Here are some recent targets:

  • Bob Huang from Morgan Stanley set a target price of $300.0 on 11/17/2025
  • Brian Meredith from UBS set a target price of $298.0 on 10/27/2025
  • Elyse Greenspan from Wells Fargo set a target price of $293.0 on 10/23/2025
  • Meyer Shields from Keefe, Bruyette & Woods set a target price of $335.0 on 10/23/2025
  • Matthew J. Carletti from JMP Securities set a target price of $325.0 on 10/22/2025
  • Jimmy Bhullar from JP Morgan set a target price of $327.0 on 10/09/2025
  • Alex Scott from Barclays set a target price of $310.0 on 10/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles